1Banda N, Nakarmura T, Matsumura M, et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int, 2000,58:684-690.
2Wada T, Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial of human diabetic nephropathy. Kidney Int, 2000,58:1492-1499.
3Ihm CG, Park JK, Hong SP, et al. A high glucose concentration stimulates the expression of monocyte chemotacic peptide-1 in human mesangial cells. Nephron, 1998,79:33-37.
4Di Paolo S, Grandaliano G, Gesualdo L, et al. Low density lipoproteins enhances transforming growth factor-beta 1 (TGF-beta 1) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells. Clin Exp Immunol, 1994,117:355-360.
5Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, et al. Angiotensin Ⅱ participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J Immumol, 1998,161:430-439.
6Sassy-Prigent C, Heudes D, Mandet C, et al. Early glomerular marcrophage recruitment in streptozotocin-induced diabetic rats. Diabetes, 2000,49:466-475.
8Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005, 54: 1615-1625.
9Villegas I, Martin AR, Toma W, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur J Pharmacol, 2004, 505: 195-203.
10Collino M, Aragno M, Mastrocola R, et al. Modulation of the oxidative stress and inflammatory response by PPAR- gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol, 2006, 530: 70-80.
